Cytokine responses during acute simian Plasmodium cynomolgi and Plasmodium knowlesi infections

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 6, 2002, Pages 586-596

  Praba Egge, Anita D ^a   Montenegro, Sonia ^b,c   Cogswell, Frank B ^b   Hopper, Terryl ^b,c   James, Mark A ^a  

^a TULANE UNIVERSITY   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEVER; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; MALARIA; NONHUMAN; PARASITEMIA; PLASMODIUM CYNOMOLGI; PLASMODIUM KNOWLESI; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SEROLOGY; WEIGHT REDUCTION;

ANIMALIA; MACACA MULATTA; PLASMODIUM CYNOMOLGI; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM VIVAX; PRIMATES; PROTOZOA; SIMIAE;

EID: 0036908240     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.586     Document Type: Article

References (24)

1. Campbell CC, 1997. Malaria: An emerging and re-emerging global plague. FEMS Immunol Med Microbiol 18: 325-331.
2. Collins WE, 1988: Major animal models in malaria research: Simian. Wernsdorfer W, McGregor S, eds. Malaria: Principles and Practice of Malariology. London: Churchill Livingston, 1473-1501.
3. Waters AP, Higgins DG, McCutchan TF, 1993. Evolutionary relatedness of some primate models of Plasmodium. Mol Biol Evol 10: 914-923.
4. Garnham PCC, Baker JR, Nesbitt PE, 1962. Differential diagnosis of bastianelli and vivax malaria. Bull World Health Organ 27:199-202.
5. Cogswell FB, 1992. The hypnozoite and relapse in primate malaria. Clin Microbiol Rev 5: 26-35.
6. Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, James MA, 1998. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Am J Trop Med Hyg 58: 119-121.
7. Kotake S, Schumacher HR Jr, Wilder RL, 1996. A simple nested RT-PCR method for quantitation of the relative amounts of multiple cytokine mRNAs in small tissue samples. J Immunol Methods 199: 193-203.
8. Schmidt LH, Fradkin R, Genther CS, Rossan RN, Squires W, Hughes HB, 1982. Plasmodium cynomolgi infections in the rhesus monkey. Am J Trop Med Hyg 31: 609-703.
9. Coatney GR, Collins WE, Warren M, Contacos P, 1971. Plasmodium Cynomolgi and Plasmodium Knowlesi. The Primate Malarias. Washington, DC: U.S. Department of Health, Education, and Welfare, U.S. Government Printing Office, 69-98 and 317-333.
10. Clark IA, Cowden WB, 1999. Why is the pathology of falciparum worse that that of vivax malaria? Parasitol Today 15: 458-461.
11. Luty AJF, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Lukner D, Greve B, Matousek P, Herbich K, Schmid D, Weinberg JB, Kremsner PG, 2000. Low interleukin-12 activity in severe Plasmodium falciparium malaria. Infect Immun 68: 3909-3915.
12. May J, Lell B, Luty AJF, Meyer CG, Kremsner PG, 2000. Plasma interleukin-10: Tumor necrosis factor (TNF)-α ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 182: 1570-1573.
13. Perkins DJ, Weinberg JB, Kremsner PG, 2000. Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J Infect Dis 182: 988-992.
14. Akanmori BD, Kurtzhals JA, Goka BQ, Adabayeri V, Ofori MF, Nkrumah FK, Behr C, Hviid L, 2000. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw 11: 113-118.
15. Troye-Blomberg M, Riley EM, Kabilan L, Holmberg Perlmann H, Andersson U, Heusser CH, Perlmann P, 1990. Production by activated human T cells of interleukin 4 but not interferongamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci USA 87: 5484-5488.
16. Cruz Cubas AB, Gentilini M, Monjour L, 1994. Cytokines and T-cell response in malaria. Biomed Pharmacother 48: 27-34.
17. Yang C, Xiao L, Tongren JE, Sullivan J, Lal A, Collins WE, 1999. Cytokine production in rhesus monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg 61: 226-229.
18. Fell AH, Smith NC, 1998. Immunity to asexual blood stages of Plasmodium is resistance to acute malaria adaptive or innate? Parasitol Today 14: 364-369.
19. Taylor-Robinson AW, Smith EC, 1999. A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection. Immunol Rev 1171: 105-124.
20. Hirunpetcharat C, Finkelman F, Clark IA, Good MF, 1999. Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol 21: 319-329.
21. Plebanski M, Flanagan KL, Lee EAM, Reece WHH, Har K, Gelder C, Gillespie G, Pinder M, Hill AVS, 1999. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 10: 651-660.
22. Stevenson M, Tam MF, Wolf SF, Sher A, 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide- dependent mechanism. J Immunol 155: 2545-2556.
23. Mohan K, Moulin P, Stevenson MM, 1997. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 159: 4990-4998.
24. Taylor-Robinson AW, 1995. Regulation of immunity to malaria: Valuable lessons learned from murine models. Parasitol Today 11:334-342.